Sonoma Pharmaceuticals ($SNOA) just dropped one of its strongest quarters in years
U.S. sales up +141%, that alone tells you something has clearly shifted
Revenue came in strong, margins improved, and they even turned EBITDA positive for the first time. That's a real change in direction
They're sitting on around $5M cash, which is decent for their size, especially with costs staying under control while growth is picking up Also worth keeping in mind:
This company has a history of moving 70-80% on much smaller news than this
This isn't just a normal beat. It's one of the most meaningful updates they've had in a long time
I called it. 🚀
